ROYAL BANK OF CANADA - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 62 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.77 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$0
-100.0%
56
-63.9%
0.00%
Q4 2020$1,0000.0%155
-75.7%
0.00%
Q3 2020$1,000
-50.0%
637
-30.3%
0.00%
Q2 2020$2,0000.0%914
+3.7%
0.00%
Q1 2020$2,000
+100.0%
881
+114.4%
0.00%
Q4 2019$1,000
-50.0%
411
-26.6%
0.00%
Q3 2019$2,0000.0%560
-18.2%
0.00%
Q2 2019$2,0000.0%6850.0%0.00%
Q1 2019$2,0000.0%685
-15.4%
0.00%
Q4 2018$2,000
-83.3%
810
-42.0%
0.00%
Q3 2018$12,0001,3960.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Broadfin Capital, LLC 486,604$1,348,0000.18%
SPHERA FUNDS MANAGEMENT LTD. 445,558$1,234,0000.14%
Baker Brothers Advisors 4,836,237$13,396,0000.11%
Kassirer Asset Management Corp 19,341$54,0000.05%
Quantitative Systematic Strategies LLC 23,427$65,0000.02%
MYCIO WEALTH PARTNERS, LLC 55,815$155,0000.01%
Assenagon Asset Management S.A. 416,241$1,153,0000.01%
OXFORD ASSET MANAGEMENT LLP 165,626$459,0000.01%
Candriam S.C.A. 290,000$803,0000.01%
ZACKS INVESTMENT MANAGEMENT 168,781$468,0000.01%
View complete list of IDERA PHARMACEUTICALS INC shareholders